Find latest MCL videos · 100+ videos
C

FDA Approval of Acalabrutinib + BR for 1L MCL: Ph3 ECHO Trial & Subgroup Analysis

By Chan Cheah 7 Videos
196 views
January 31, 2025
Comments 0
Login to view comments. Click here to Login

Featured Video

12:58
Incyte

Spleen Volume Reduction and Long-Term Survival in Myelofibrosis: Whe…

Feat. R. Mesa

Featured Video

45:42
Amgen Sponsorship

FDA Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Related Videos

International Congress on Cancer Metastasis

10th International Congress on Cancer Metastasis

Wed, Oct 29, 2025
23:28

Indy Hematology Review 2025: State of the Art 2025 - Emerging Therap…

Indy Hematology Review 2025

R. Birhiray

538 views
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

5.1K views
33:46

ASH 2024 Review: Key Updates in Non-Hodgkin Lymphoma

Cleveland Clinic Taussig Cancer Institute

P. Caimi

280 views
27:04

ASH 2024 Treatment Updates in Lymphoma: Practice Changing and Promis…

UChicago Medicine

A. Rojek

220 views
16:57

ASCO® 2024 Summary: "Lymphoma Highlights"

2024 ASCO® Annual Meeting Insights Hub

B. D. Cheson

1.8K views
19:10

Steroid-Refractory GVHD Updates

Roswell Park Comprehensive Cancer Center

S. Holtan

281 views
07:37

Tandem 2025 Insights: PTCy-Based GVHD Prophylaxis After Mismatched U…

Insights from 2025 Tandem Annual Meeting

M. Al Malki

156 views
17:24

ESMO 2024 Summary: Updates in the Treatment of MCL

2024 ESMO Annual Meeting Insights Hub

G. Hess

327 views
20:16

Indy Hematology Review 2025: Managing the Controversies in the Treat…

Indy Hematology Review 2025

M. Wang

80 views
19:33

Acute GVHD: Demographics, Diagnosis, Pathophysiology, and Advancemen…

City of Hope

A. Salhotra

146 views
13:43

ASH 2025 Review: Key Trials and Takeaways in 1L MCL Treatment in You…

University of Colorado Division of Hematology

T. Phillips

59 views
25:47

Practice-Changing Updates in Indolent B-Cell Lymphomas

Massachusetts General Hospital Cancer Center

J. Soumerai

536 views
11:44

Axatilimab in cGVHD: Mechanism of Action and Comparison With Current…

Noah Merin

147 views
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

988 views
25:22

Treatment Updates and Management of Non-Hodgkin Lymphomas

Integrity CE

D. Wallace, M. Cortese

123 views
27:52

Yale Cancer Center Updates on B-Cell Lymphomas: MCL, Aggressive LBCL…

Yale Cancer Center

S. Kothari

31 views
04:09

Common Toxicities Associated With Allogeneic HSCT

GRACE

M. Salman Faisal

76 views
08:07

Identifying Steroid-Refractory or Steroid-Dependent cGVHD and the Ro…

Elisabetta Xue

73 views
16:43

The Role of Axatilimab in Targeting CSF1R for Inflammation and Fibro…

Daniel Wolff

182 views
06:24

The Pivotal ROCKstar Study: Evaluation of Belumosudil in a Real-Worl…

Aravind Ramakrishnan

51 views
AUTOPLAY